Activity of N-acetyl-L-cysteine against biofilm of Staphylococcus aureus and Pseudomonas aeruginosa on orthopedic prosthetic materials

International Journal of Artificial Organs

Volumn 36, Issue 1, 2013, Pages 39-46

  Drago, Lorenzo ^a,b   De Vecchi, Elena ^a   Mattina, Roberto ^b   Romanò, Carlo L ^a  

^a IRCCS ISTITUTO ORTOPEDICO GALEAZZI   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Bacterial biofilm; N acetyl L cysteine; Prosthetic joint infections; Pseudomonas aeruginosa; Staphylococcus aureus

Indexed keywords

AMINO ACIDS; BIOFILMS; POLYETHYLENES; PROSTHETICS; TITANIUM;

BACTERIAL BIOFILM; N-ACETYL-L-CYSTEINE; ORTHOPAEDIC IMPLANT INFECTIONS; P.AERUGINOSA; PROSTHETIC JOINT INFECTION; PROSTHETIC JOINTS; PSEUDOMONAS AERUGINOSA; S. AUREUS; SAND-BLASTED TITANIUM; TITANIUM DISKS;

BACTERIA;

ACETYLCYSTEINE; AMIKACIN; CEFEPIME; CEFOTAXIME; CEFTRIAXONE; CIPROFLOXACIN; COLISTIN; ERYTHROMYCIN; GENTAMICIN; GLYCOPEPTIDE; LEVOFLOXACIN; LINEZOLID; METICILLIN; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BIOFILM; CONFOCAL LASER MICROSCOPY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROSTHESIS INFECTION; PROSTHESIS MATERIAL; PSEUDOMONAS AERUGINOSA; SPECTROPHOTOMETRY; STAPHYLOCOCCUS AUREUS;

EID: 84874220491     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.5301/ijao.5000135     Document Type: Article

References (25)

1. Esposito S, Leone S. Prosthetic joint infections: microbiolo-gy, diagnosis, management and prevention. Int J Antimicrob Agents. 2008;32(4):287-293.
2. Trampuz A, Zimmerli W. Diagnosis and treatment of implant-associated septic arthritis and osteomyelitis. Curr Infect Dis Rep. 2008;10(5):394-403.
3. Hsieh PH, Lee MS, Hsu KY, Chang YH, Shih HN, Ueng SW. Gram-negative prosthetic joint infections: risk factors and outcome of treatment. Clin Infect Dis. 2009;49(7):1036-1043.
4. Marculescu CE, Cantey JR. Polymicrobial prosthetic joint infections: risk factors and outcome. Clin Orthop Relat Res. 2008;466(6):1397-1404.
5. Piper KE, Jacobson MJ, Cofield RH, et al. Microbiologic di-agnosis of prosthetic shoulder infection by use of implant sonication. J Clin Microbiol. 2009;47(6):1878-1884.
6. Wright JA, Nair SP. Interaction of staphylococci with bone. Int J Med Microbiol. 2010;300(2-3):193-204.
7. Montanaro L, Speziale P, Campoccia D, et al. Scenery of Staphylococcus implant infections in orthopedics. Future Microbiol. 2011;6(11):1329-1349.
8. Gallo J, Landor I, Vavrík P. Soucasné moznosti prevence infekcí kloubních náhrad (in Czech) [Current strategies for prevention of prosthetic joint infection]. Acta Chir Orthop Traumatol Cech. 2006;73(4):229-236.
9. Geipel U. Pathogenic organisms in hip joint infections. Int J Med Sci. 2009;6(5):234-240.
10. Matthews PC, Berendt AR, McNally MA, Byren I. Diagno-sis and management of prosthetic joint infection. BMJ. 2009;338:1773b.
11. Rohde H, Burandt EC, Siemssen N, et al. Polysaccharide intercellular adhesin or protein factors in biofilm accumu-lation of Staphylococcus epidermidis and Staphylococcus aureus isolated from prosthetic hip and knee joint infec-tions. Biomaterials. 2007;28(9):1711-1720.
12. Aslam S. Effect of antibacterials on biofilms. Am J Infect Control. 200836(10):S175.e9-S175.e11.
13. Olofsson AC, Hermansson M, Elwing H. N-acetyl-L-cysteine affects growth, extracellular polysaccharide production, and bacterial biofilm formation on solid surfaces. Appl Environ Microbiol. 2003;69(8):4814-4822.
14. Sheffner AL. The mucolytic action of acetylcysteine. Tuber-culol Thorac Dis. 1966;23(2):31-33.
15. Christensen GD, Simpson WA, Younger JJ, et al. Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococ-ci to medical devices. J Clin Microbiol. 1985;22(6):996-1006.
16. Clinical and Laboratory Standards Institute. Methods for di-lution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved standard-Eighth Edition. M070-A8. Wayne, PA: CLSI; 2009.
17. Trampuz A, Piper KE, Jacobson MJ, et al. Sonication of re-moved hip and knee prostheses for diagnosis of infection. N Engl J Med. 2007;357(7):654-663.
18. Pérez-Giraldo C, Rodríguez-Benito A, Morán FJ, Hurtado C, Blanco MT, Gómez-García AC. Influence of N-acetylcysteine on the formation of biofilm by Staphylococcus epidermidis. J Antimicrob Chemother. 1997;39(5):643-646.
19. Zhao T, Liu Y. N-acetylcysteine inhibit biofilms produced by Pseudomonas aeruginosa. BMC Microbiol. 2010;10:140.
20. Aslam S, Trautner BW, Ramanathan V, Darouiche RO. Combination of tigecycline and N-acetylcysteine reduces biofilm-embedded bacteria on vascular catheters. Antimi-crob Agents Chemother. 2007;51(4):1556-1558.
21. Aslam S, Darouiche RO. Role of antibiofilm-antimicrobial agents in controlling device-related infections. Int J Artif Organs. 2011;34(9):752-758.
22. El-Feky MA, El-Rehewy MS, Hassan MA, Abolella HA, Abd El-Baky RM, Gad GF. Effect of ciprofloxacin and N-- acetylcysteine on bacterial adherence and biofilm formation on ureteral stent surfaces. Pol J Microbiol. 2009;58(3):261-267.
23. Oga M, Arizono T, Sugioka Y. Bacterial adherence to bioinert and bioactive materials studied in vitro. Acta Orthop Scand. 1993;64(3):273-276.
24. Arnold JW, Bailey GW. Surface finishes on stainless steel reduce bacterial attachment and early biofilm formation: scanning electron and atomic force microscopy study. Poult Sci. 2000;79(12):1839-1845.
25. Gordon CA, Hodges NA, Marriott C. Use of slime disper-sants to promote antibiotic penetration through the extracel-lular polysaccharide of mucoid Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1991;35(6):1258-1260.